181 related articles for article (PubMed ID: 16378095)
21. Therapeutic potential of RNA interference against cancer.
Takeshita F; Ochiya T
Cancer Sci; 2006 Aug; 97(8):689-96. PubMed ID: 16863503
[TBL] [Abstract][Full Text] [Related]
22. Effects of rapamycin on accumulation of alpha-, beta- and gamma-globin mRNAs in erythroid precursor cells from beta-thalassaemia patients.
Fibach E; Bianchi N; Borgatti M; Zuccato C; Finotti A; Lampronti I; Prus E; Mischiati C; Gambari R
Eur J Haematol; 2006 Nov; 77(5):437-41. PubMed ID: 16939628
[TBL] [Abstract][Full Text] [Related]
23. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors.
Sun Y; Li Z; Li L; Li J; Liu X; Li W
Int J Mol Med; 2007 Apr; 19(4):705-11. PubMed ID: 17334648
[TBL] [Abstract][Full Text] [Related]
24. Complete knockdown of CCR5 by lentiviral vector-expressed siRNAs and protection of transgenic macrophages against HIV-1 infection.
Anderson J; Akkina R
Gene Ther; 2007 Sep; 14(17):1287-97. PubMed ID: 17597795
[TBL] [Abstract][Full Text] [Related]
25. High oxygen environment during pregnancy rescues sickle cell anemia mice from prenatal death.
Ye L; Chang JC; Lu R; Kan YW
Blood Cells Mol Dis; 2008; 41(1):67-72. PubMed ID: 18207438
[TBL] [Abstract][Full Text] [Related]
26. Glycoprotein Ibalpha promoter drives megakaryocytic lineage-restricted expression after hematopoietic stem cell transduction using a self-inactivating lentiviral vector.
Lavenu-Bombled C; Izac B; Legrand F; Cambot M; Vigier A; Massé JM; Dubart-Kupperschmitt A
Stem Cells; 2007 Jun; 25(6):1571-7. PubMed ID: 17379771
[TBL] [Abstract][Full Text] [Related]
27. Knock-down of gene expression in hematopoietic cells.
Scherr M; Venturini L; Eder M
Methods Mol Biol; 2009; 506():207-19. PubMed ID: 19110629
[TBL] [Abstract][Full Text] [Related]
28. An in vitro system for efficiently evaluating gene therapy approaches to hemoglobinopathies.
Howrey RP; El-Alfondi M; Phillips KL; Wilson L; Rooney B; Lan N; Sullenger B; Smith C
Gene Ther; 2000 Feb; 7(3):215-23. PubMed ID: 10694798
[TBL] [Abstract][Full Text] [Related]
29. Ribonucleic acid interference for neurological disorders: candidate diseases, potential targets, and current approaches.
Federici T; Boulis NM
Neurosurgery; 2007 Jan; 60(1):3-15; discussion 15-6. PubMed ID: 17228249
[TBL] [Abstract][Full Text] [Related]
30. Erythroid-specific expression of beta-globin by the sleeping beauty transposon for Sickle cell disease.
Zhu J; Kren BT; Park CW; Bilgim R; Wong PY; Steer CJ
Biochemistry; 2007 Jun; 46(23):6844-58. PubMed ID: 17508724
[TBL] [Abstract][Full Text] [Related]
31. In vivo gene silencing in solid tumors by targeted electrically mediated siRNA delivery.
Golzio M; Mazzolini L; Ledoux A; Paganin A; Izard M; Hellaudais L; Bieth A; Pillaire MJ; Cazaux C; Hoffmann JS; Couderc B; Teissié J
Gene Ther; 2007 May; 14(9):752-9. PubMed ID: 17344906
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of safety and efficacy of RNAi against HIV-1 in the human immune system (Rag-2(-/-)gammac(-/-)) mouse model.
ter Brake O; Legrand N; von Eije KJ; Centlivre M; Spits H; Weijer K; Blom B; Berkhout B
Gene Ther; 2009 Jan; 16(1):148-53. PubMed ID: 18668146
[TBL] [Abstract][Full Text] [Related]
33. Genetic strategies for the treatment of sickle cell anaemia.
Mansilla-Soto J; Rivière I; Sadelain M
Br J Haematol; 2011 Sep; 154(6):715-27. PubMed ID: 21707580
[TBL] [Abstract][Full Text] [Related]
34. Determinants of specific RNA interference-mediated silencing of human beta-globin alleles differing by a single nucleotide polymorphism.
Dykxhoorn DM; Schlehuber LD; London IM; Lieberman J
Proc Natl Acad Sci U S A; 2006 Apr; 103(15):5953-8. PubMed ID: 16585504
[TBL] [Abstract][Full Text] [Related]
35. Gene Therapy for Sickle Cell Disease: A Lentiviral Vector Comparison Study.
Urbinati F; Campo Fernandez B; Masiuk KE; Poletti V; Hollis RP; Koziol C; Kaufman ML; Brown D; Mavilio F; Kohn DB
Hum Gene Ther; 2018 Oct; 29(10):1153-1166. PubMed ID: 30198339
[TBL] [Abstract][Full Text] [Related]
36. Screening for trans-acting factors and other factors involved in the activating or silencing of the gamma-globin gene during human ontogeny.
Ma YN; Zhang X; Zhang JW; Zhang XH; Wang RX
Biochem Cell Biol; 2007 Jun; 85(3):347-57. PubMed ID: 17612629
[TBL] [Abstract][Full Text] [Related]
37. siRNA-mediated reduction of alpha-globin results in phenotypic improvements in beta-thalassemic cells.
Voon HP; Wardan H; Vadolas J
Haematologica; 2008 Aug; 93(8):1238-42. PubMed ID: 18556409
[TBL] [Abstract][Full Text] [Related]
38. A universal transgene silencing method based on RNA interference.
Mangeot PE; Cosset FL; Colas P; Mikaelian I
Nucleic Acids Res; 2004 Jul; 32(12):e102. PubMed ID: 15249598
[TBL] [Abstract][Full Text] [Related]
39. A versatile tool for conditional gene expression and knockdown.
Szulc J; Wiznerowicz M; Sauvain MO; Trono D; Aebischer P
Nat Methods; 2006 Feb; 3(2):109-16. PubMed ID: 16432520
[TBL] [Abstract][Full Text] [Related]
40. Understanding mechanisms of gamma-globin gene regulation to develop strategies for pharmacological fetal hemoglobin induction.
Pace BS; Zein S
Dev Dyn; 2006 Jul; 235(7):1727-37. PubMed ID: 16607652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
